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Toward optimal implementation of cancer
prevention and control programs in public
health: a study protocol on misimplementation
Margaret Padek1* , Peg Allen1, Paul C. Erwin2, Melissa Franco1, Ross A. Hammond3, Benjamin Heuberger3,
Matt Kasman3, Doug A. Luke4, Stephanie Mazzucca1, Sarah Moreland-Russell1 and Ross C. Brownson1,5

Abstract
Background: Much of the cancer burden in the USA is preventable, through application of existing knowledge.
State-level funders and public health practitioners are in ideal positions to affect programs and policies related to
cancer control. Mis-implementation refers to ending effective programs and policies prematurely or continuing
ineffective ones. Greater attention to mis-implementation should lead to use of effective interventions and more
efficient expenditure of resources, which in the long term, will lead to more positive cancer outcomes.
Methods: This is a three-phase study that takes a comprehensive approach, leading to the elucidation of tactics for
addressing mis-implementation. Phase 1: We assess the extent to which mis-implementation is occurring among
state cancer control programs in public health. This initial phase will involve a survey of 800 practitioners
representing all states. The programs represented will span the full continuum of cancer control, from primary
prevention to survivorship. Phase 2: Using data from phase 1 to identify organizations in which mis-implementation
is particularly high or low, the team will conduct eight comparative case studies to get a richer understanding of
mis-implementation and to understand contextual differences. These case studies will highlight lessons learned
about mis-implementation and identify hypothesized drivers. Phase 3: Agent-based modeling will be used to
identify dynamic interactions between individual capacity, organizational capacity, use of evidence, funding, and
external factors driving mis-implementation. The team will then translate and disseminate findings from phases 1 to
3 to practitioners and practice-related stakeholders to support the reduction of mis-implementation.
Discussion: This study is innovative and significant because it will (1) be the first to refine and further develop
reliable and valid measures of mis-implementation of public health programs; (2) bring together a strong,
transdisciplinary team with significant expertise in practice-based research; (3) use agent-based modeling to address
cancer control implementation; and (4) use a participatory, evidence-based, stakeholder-driven approach that will
identify key leverage points for addressing mis-implementation among state public health programs. This research
is expected to provide replicable computational simulation models that can identify leverage points and public
health system dynamics to reduce mis-implementation in cancer control and may be of interest to other health
areas.
Keywords: Mis-implementation, Cancer control, Agent-based models
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Background
Cancer continues to be the second most common cause
of death in the USA [1, 2]; however, much of this burden
is preventable through evidence-based interventions [3].
Substantial potential for cancer control exists at the state
level [4, 5] in which all states retain enormous authority
to protect the public’s health [6]. States shoulder their
broad public health responsibilities through work carried
out by state and local health agencies. Over $1.1 billion
annually is expended on state cancer control programs1
(i.e., primary and secondary prevention) [7, 8], which is
significantly higher than any other area of chronic disease
prevention and control. However, cancer control covers a
broad spectrum of programs, and funding can be limited
in areas and population groups with high cancer burdens
[9]. With the limited resources available to state-level programs, the need to utilize the best available evidence to
implement and sustain these programs is key to the
efficiency of cancer control at the state level [10].
Evidence-based approaches to cancer control can
significantly reduce the burden of cancer [10–13]. This
approach begins with an estimate of the preventable
burden. Depending on the methods, between one third
and one half of deaths due to cancer can be preventable
[3, 14, 15]. Large-scale efforts such as Cancer Control P.
L.A.N.E.T. and the Community Guide have now placed a
wide array of evidence-based interventions in the hands of
cancer control practitioners [13, 16, 17]. Despite those efforts, a set of agency-level structures and processes (e.g.,
leadership, organizational climate and culture, access to research information) needs to be present for evidence-based
decision-making (EBDM) to grow and thrive [10, 18–20].
While efforts are building to make sure practitioners have
access to and the capacity for EBDM [21], the need for the
exploration of mis-implementation of these programs in
public health is growing.
Importance and potential impact of mis-implementation

The scientific literature has begun to highlight the importance of considering de-implementation in health care and
public health [22, 23]. While de-implementation looks at
the retraction of unnecessary or overused care [23, 24], it
does not quite fully examine the processes that sustain
non-evidence-based programs and the de-implementation
of programs that are, in fact, evidence-based. An example
of the discontinuation of an evidence-based program is
notable with the VERB campaign in the USA that demonstrated effectiveness in increasing physical activity of children but was then discontinued [25, 26]. On the other end
of the mis-implementation spectrum is the continuation
of non-evidence-based programs such as the continuation
of the DARE (Drug Abuse Resistance Education) program
despite many evaluations have demonstrated its limited
effectiveness [27, 28]. That is why researchers have come
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to define mis-implementation as the process where effective interventions are ended or ineffective interventions are
continued in health settings (i.e., EBDM is not occurring)
[22, 24]. Most of the current literature focuses on the
overuse and underuse of clinical interventions and the
cultural and organizational shifts needed toward the acceptance of de-adoption within medicine [29]. Currently,
over 150 commonly used medical practices have been
deemed ineffective or unsafe [23]. Despite this discovery
within the medical realm, there is still sparse literature on
mis-implementation in the field of public health or cancer
control.
It is already known that there are a number of cancer
control programs that continue without a firm basis in
scientific evidence [12]. Hannon and colleagues reported
that less than half of cancer control planners had ever
used evidence-based resources [12]. Previous studies
have suggested that between 58 and 62% of public health
programs are evidence-based [30, 31]. Even among programs that are evidence-based, 37% of chronic disease
prevention staff in state health departments reported
programs are often or always discontinued when they
should continue [22].
Factors likely to affect mis-implementation

In delivery of mental health services, Massatti and colleagues
made several key points regarding mis-implementation: (1)
the right mix of contextual factors (e.g., organizational support) is needed for the continuation of effective programs in
real-world settings; (2) there is a significant cost burden of
the programs to the agency; and (3) understanding the nuances of early adopters promotes efficient dissemination of
effective interventions [32]. Management support for EBDM
in public health agencies are associated with improved public health performance [18, 33], but little is known about the
processes and factors that affect mis-implementation
specifically. Pilot data indicate that organizational supports for EBDM may be protective against misimplementation (e.g., leadership support for EBDM,
having a work unit with the necessary EBDM skills)
[22]. In addition, engaging a diverse set of partners may
also lower the likelihood of mis-implementation.
The utility of agent-based modeling for studying public
health practice

Agent-based modeling (ABM) is a powerful tool being
used to inform practice and policy decisions in numerous
health-related fields [34]. ABM is a type of computational
simulation modeling in which individual agents—who
may be people, organizations, or other entities—are defined according to mathematical rules and interact with
one another and with their environment over time
[35]. ABM is a useful tool to observe the dynamic and
interdependent relationships between heterogeneous
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agents within a complex system and how system-level
behavior and outcomes evolve over time from the
interaction between these individual agents (emergent
behavior) [35–37].
Agent-based models have a strong track record in social and biological sciences and have been widely used to
study infectious disease control [38, 39] and health care
delivery [40, 41]. More recently, ABM has begun to be
applied to chronic disease control, ranging from the
study of etiology, to intervention design, to policy implementation [35, 40, 42–44]. In topics specific to cancer
prevention, ABMs are now being used to show how individuals respond to tobacco control policies [45] and to
better understand the community-level, contextual factors
involved in implementing childhood obesity interventions
[43]. Some of the advantages of employing ABMs include
that they can (1) model bi-directional and non-linear interactions between individuals, organizations, and external
contextual factors [46]; (2) describe dynamic decisionmaking processes [47]; (3) simulate adaptation, counterfactuals, and relational structures such as networks [34, 42];
(4) consider and capture extensive heterogeneity across
different entities or populations [48]; and (5) act as “policy
laboratories” for researchers when real-world experimentation is not feasible or is too costly [48]. ABM has the potential to pinpoint both the factors within state health
departments that have the greatest effect on the misimplementation of cancer control programs and the leverage points that may be good targets to improve successful
implementation.
Early on, ABMs primarily relied on simple heuristic
rules as models of human behavior and were generally
limited in their ability to predict behaviors of larger
populations and complex interactions. In recent years,
however, ABMs have provided (1) more refined representations of behavior and decision-making [49, 50], (2)
increasingly sophisticated representations of relational/environmental structures such as geography and networks
[34, 42], and (3) greater focus on “co-evolution” across

Fig. 1 Study schema
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levels of scale across settings, including organizational
dynamics as in political science [34, 47].

Methods/design
This is a multi-part, observational study funded by the
National Cancer Institute that will examine the factors that
affect mis-implementation of cancer control programs.
ABM will be used here to understand influences of
individual, organizational, and external factors on program
implementation, decision-making, and the behaviors of
professionals within state health departments. See Fig. 1 for
a visual of the study schema. The project is outlined in the
following three phases: (1) assessing mis-implementation,
(2) conducting comparative case studies, and (3) agentbased modeling. The study design has been approved by
the Washington University Institutional Review Board.
Phase 1, assessing mis-implementation (Aim 1)

The measures to assess the scope and patterns of the misimplementation problem are vastly under-developed. There
has been limited pilot work in this area [22]; therefore,
phase 1 will focus on the refinement of measures and assessment of the patterns of mis-implementation in cancer
control in the USA. The project begins by refining and pilot
testing measures to assess mis-implementation within state
health departments. The foundation of these measures
comes from a pilot survey previously completed by
members of the team, the Mis-Implementation Survey for
Cancer Control [22, 51–58]. The project team has engaged
a group of public health practitioners who will serve as an
advisory group throughout the duration of the project and
will help inform the development of the measures.
The first step in exploring mis-implementation is to
build the self-report survey instrument. To do so, the
team will search for existing instruments using formal
queries of the published literature. The team will search
public health, sustainability, and clinical and agent-based
modeling literature. Search terms include Evidence-based
decision making AND De-Implement* AND Measures;
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sustain*; de-implement* AND Measures; de-adopt* OR
de-implement*; de-implement AND Health AND instrument; Organization* Capacity AND Measures. Candidate
instruments will also be provided by the research team,
lead authors of collected literature, and bibliography reviews [59]. Identified measures will be cataloged, and the
authors will be queried for the related instruments. Relevant instruments will be summarized into evidence tables,
highlighting core constructs, audience, and measurement
properties. See Fig. 2 for the conceptual framework that
will guide the survey development.
Using the evidence tables, a draft instrument will be
developed. It is likely to cover seven main domains:
(1) biographical information; (2) frequency of misimplementation; (3) reasons for mis-implementation;
(4) barriers in overcoming mis-implementation; (5)
specific programs being mis-implemented; (6) use of
management supports for EBDM; and (7) ratings on
current level of individual skills essential for implementing evidence-based interventions.
New measures will undergo expert review for content
validity, relying on the advisory group of state health
department practitioners. Before the instrument goes
into the field, a series of individual interviews will be
completed for cognitive response testing of newly developed items. Cognitive response testing is routinely used
in refining questionnaires to improve the quality of data
collection [60–62]. Cognitive response testing will be
used to determine: (1) question comprehension (what

Fig. 2 Conceptual framework for mis-implementation
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does the respondent think the question is asking?); (2)
information retrieval (what information does the respondent need to recall from memory in order to answer
the question?); and (3) decision processing (how does the
respondent choose their answer?).
Once cognitive testing is completed, additional edits
will be made to the survey, and a test-retest will be
employed to assess reliability of the instrument. The
team intends to recruit around 100 practitioners, via the
advisory group to complete the survey and then
complete the survey again, 2 weeks after initial administration. Appropriate statistics will be calculated for each
type of question to assess the reliability between the two
test time points [63, 64].
Study participants

Study participants will include cancer control public
health practitioners, which include those individuals
who direct and implement population-based intervention programs in state health departments. These practitioners may be directly involved in program delivery,
may set priorities, or allocate resources for programs
related to cancer risk factors. The target audience will
be inter-disciplinary; that is, they will be drawn from
diverse backgrounds including health educators, epidemiologists, and evaluators. Examples of the individuals
in the target audience include (1) the director of a
Centers for Disease Control and Prevention (CDC)funded comprehensive cancer control program for the
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state; (2) the director of a state program addressing primary prevention of cancer (tobacco, inactivity, diet, sun
protection); (3) the director of state programs promoting early detection of breast, cervical, and colorectal
cancers among underserved populations; or (4) state
health department epidemiologists, evaluators, policy
officers, and health educators supporting cancer control
programs.
Participants will be randomly drawn from the 3000person membership of National Association of Chronic
Disease Directors (NACDD) and program manager lists
from key CDC-supported programs in cancer and cancer risk factors. The team has an established partnership with NACDD and has worked extensively with
them on previous projects [30, 54–57, 65–68]. In phase
1, the team will recruit 1040 individuals for a final sample size of 800. The team anticipates a 60% response
rate based on evidence that supports a series of emails,
follow-up phone calls, and endorsements from NACDD
leadership and officials in the states with enrolled participants [51, 52, 54, 56, 69–74]. Similar to successful
approaches in previous studies [56, 74], data will be
collected using an online survey (Qualtrics software
[75]) that will be delivered via email. The survey will
remain open for a 2-month time period with four email
reminders and two rounds of phone calls to bolster
response rates [72]. All respondents will be offered a
gift card incentive.
Analyzing the survey data

Survey data will be analyzed in three ways. First, descriptive statistics (e.g., frequencies, central tendencies, and
variabilities) and diagnostic plots (e.g., stem and leaf
plots, q-q plots) will be completed on all variables. Data
will be examined for outliers and tested as appropriate
for normality, linearity, and homoscedasticity. Appropriate corrective strategies will be used if problems are
identified. Bivariate and multivariate analyses will rely on
data at the single time point of the phase 1 survey.
These preliminary analyses are necessary to ensure highquality data and to test assumptions of the proposed
models. The team will also compare demographic and
regional variations between respondents and nonrespondents to assess potential response bias.
Next, the measurement properties of the instrument
will be comprehensively assessed. To do so, the team
will conduct confirmatory factor analysis within an explanatory framework using structural equation models
[76, 77]. Using factor analysis seeks to reduce the anticipated large number of items in the survey tool to a
smaller number of underlying latent variables while
examining construct validity of the measures [78]. The
initial domains to be used in factor analysis are shown
in Fig. 2.
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Finally, multivariate analyses will use general linear or
logistic mixed-effects modeling. A mixed-effects approach
allows the team to include continuous predictors, both
fixed and random categorical effects, and allows us to
model the variability due to the nested design (individuals
nested in health departments). The mixed-effects model
will assess effects of multiple predictors on two key
dependent variables (Yij) (ending programs that should
continue, continuing programs that should end). The
team will be able to assess covariate effects of numerous
variables such as gender, educational background, and
time in current job position. Here is a sample model:
Y ij ¼ β0 j þ β1 Pij þ β2 Rij þ β3 S ij þ β4 ðPRÞij þ μ j þ εij
where Pij and Sij are the fixed effects for program type
and state population size, Rij is a fixed effect for reason
for mis-implementation, (PR)ij is the program by reason
interaction, and μj and εij are the variance components
at the state and individual levels, respectively. The
mixed-effects modeling allows for random effects at the
state (μj) level. A mixed-effects model will examine
state-level variability and account for the nested design
of the study [79].
Sample size calculations

For the factor analysis, given a minimum of four items
per factor and expected factor loading of 0.6 or higher,
the survey will need a sample of 400 [80]. For reliability
testing, for statistically significant (p < 0.05) kappa values
of 0.50 and 0.70, the sample size requirements are 50
and 25 pairs, respectively, in each of the two groups. To
estimate an intraclass correlation coefficient of 0.90 or
above (power 0.80, p < 0.05), 45 pairs are required in
each subgroup. Sample size estimates are based on
Dunn’s recommendations [81]. Therefore, a sample of
100 for reliability testing will provide high power.
For population-level estimates of mis-implementation
and multivariate modeling, sample sizes are based on a
power ≥ 90% with two-sided α = 5% [22]. To estimate a
prevalence of mis-implementation of 37% (± 3%), a
sample of 750 is needed. To compare rates of misimplementation by program area (e.g., cancer screening
estimated at 19% versus primary prevention of cancer
estimated at 29%), a sample size of 800 is required at
power > 0.90 and p < 0.05.
Phase 2, comparative case studies (Aim 2)

Often, the key issue in understanding the translation of
research to practice is not the evidence-based intervention itself, but rather the EBDM processes by which
knowledge is transferred (i.e., contextual evidence as
described by Rychetnik et al. [82] and Brownson et al.
[10]) [83]. Building on data collected in phase 1, the goal
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of phase 2 is to better understand the context for misimplementation via case studies, which will involve key
informant interviews. These interviews will involve sites
that are successful or less than successful in addressing
mis-implementation. The purpose of key informant interviews is to collect information from a range of people
who have first-hand knowledge of an issue within a
specific organization or community.
Sampling, recruitment, and interview domains

The team will utilize purposive sampling to select participants [84]. Based on phase 1 data, eight states will be
selected—that is, four states where mis-implementation
is high and four where mis-implementation is low. Participants will be state health department practitioners
who work in the identified states. By examining extreme
cases, the study can maximize the likelihood that the
qualitative approach will provide deeper understanding
of mis-implementation, building on Aim 1 activities.
While Aim 1 will determine the extent (the “how much”)
and some underlying reasons (the “why”), Aim 2 will give
a deeper understanding of the “why” and “how” of misimplementation. The interviews will focus on several
major areas (organized around domains in Fig. 2): (1) inputs related to mis-implementation, (2) factors affecting
mis-implementation (individual, organizational, external),
and (3) methods for reducing mis-implementation.
Data collection

Study staff will make initial contact via email and by telephone to invite identified participants to the study and
arrange an appointment for the telephone interview. Participants will receive consent information in accordance
with the Washington University Institutional Review
Board standards. The team anticipates approximately 12
interviews from each of the eight state health departments
(a total of 96 interviews) and will conduct interviews until
the team reaches thematic saturation [85]. Participants
will be offered a gift card incentive.
Data coding and analysis

Digital audio recordings of the interviews will be transcribed verbatim. Two project team members will analyze
each of these transcripts via consensus coding. After
reviewing the research questions [86, 87], the team members will read five of the transcripts using a first draft of a
codebook. Each coder will be asked to systematically
review the data and organize each of the statements into
categories that summarize the concept or meaning articulated [88]. Once the first five transcripts are coded, they
will be discussed in detail to ensure the accuracy of the
codebook and inter-coder consistency. The codebook
will be edited as needed prior to coding the remainder
of the transcripts. All transcripts will be analyzed using
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NVIVO.11 [89]. After refinement of the codebook, each
transcript will be coded independently by two team
members. The two team members will then review
non-overlapping coding in the text blocks and reach
agreement on text blocking and coding. Themes from the
coded transcripts will be summarized and highlighted with
exemplary quotes from participants. Data analysis may
also include quantification or some other form of data aggregation. The study team will use the interview guide
questions to establish major categories (e.g., individual
factors, organizational factors). All information that does
not fit into these categories will be placed in an “other”
category and then analyzed for new themes. Comparisons
will be made to identify key differences in thematic issues
between those in high and low mis-implementation settings. After initial analyses by research team members,
one focus group will be conducted remotely or in-person
with state health department staff in each of the eight
states to get input on other interim theme summaries.
Phase 3, agent-based modeling

Agent-based modeling will allow the study team to
explore how mis-implementation emerges through interactions between individuals who are situated within public health organizations. The general approach will be to
model a hypothetical public health program environment, populated by individuals (agents) who are programmatic decision-makers or influencers within state
health departments. The key behavior of interest in the
simulation models will be the decision to continue or
discontinue strategies within cancer prevention and control programs in a state health department. The resulting
model will have the ability to simulate both overall trajectory of decisions being made as well as the patterns of
interacting factors that emerge in these types of decisionmaking processes [34]. The models will consider individual characteristics (from the survey) and organizational
characteristics (from the survey and archival data) across
an agency hierarchy as well as influences from contextual,
external forces that affect the state health department environments (e.g., policy changes, strengths of partnerships)
and their potential effects on mis-implementation (Fig. 3
and Table 1).
Defining the agents and contextual factors

Agents in an ABM are generally defined by individual
characteristics (properties), behavior rules that govern
choices or actions (possibly dependent on both the
agent’s own state and that of the environment) [36, 37],
and a social environment that characterizes relationships
between agents. In this case, both individual agents (the
public health professionals working in cancer prevention
and control within state health departments) and
organizational agents (the state health departments in
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Fig. 3 Agent-based model flowchart

which decisions are being made) will be influenced by
elements outside the state health department, as well as
by interactions with each other.
The complexity of the systems in which the organizational
and external factors operate and influence public health
practitioner decision-making is such that ABM will be able
to provide greater insight than traditional experimental
design or epidemiological and econometric analytic
tools which require assumptions about homogeneity,
linearity, etc. that are not appropriate for complex
organizational systems [36, 90]. By developing a model
that is informed by survey and case study data, we will
be able to help explain how mis-implementation arises
from decisions made by individuals within specific
organizational and external contexts. Additionally, ABM

can provide insight into potential counterfactuals and implications these may have for intervention designs and targeting (e.g., if a particular organizational climate had been
present, mis-implementation would not have occurred).
The potential benefits of using an ABM approach include
anticipating both the individual impact of modifiable
influences on decision-making and the organizational impacts of mis-implementation in varying conditions [43].
In our planned initial model design, individual-level
agents will work within a health department, making periodic choices about whether to continue or discontinue
specific intervention strategies within cancer prevention
and control programs. The team will explore the impact
that the underlying factors of state health departments
have on the patterns of mis-implementation. The team has

Table 1 Sample agents and contextual factors
Domain

Model-relevant construct

Sample elements

Sources

Agent (individual)

Attitudes

- Appeal of evidence-based practices
- Openness to innovation

Aarons et al. [97]

Skills

- Use economic evaluation in the decision-making process
- Adapt programs for different communities and settings

Gibbert et al. [31]
Jacob et al. [56]

Barriers

- Lack of knowledge of EBDM
- General resistance to changing old practices

Maylahn et al. [98]
Jacobs et al. [57]

Resources

- Program funding
- Expertise of available staff

Erwin et al. [99]
Brownson et al. [52]

Leadership/management support

- Agency leadership values EBDM
- Management practices of direct supervisor

Brownson et al. [18]
Jacob et al. [56]

Barriers

- Lack of incentives in the agency for EBDM
- Organizational culture does not support EBDM

Jacobs et al. [57]
Gibbert et al. [31]

Partnerships

- Maintains a diverse set of partners
- Compatible processes between partners

Brownson et al. [18]
Massatti et al. [32]

Policy support

- Supportive state legislature
- Supportive governor

Brownson et al. [52]

Agent (organizational)

Contextual (external)
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developed the initial set of individual and organizational
agent constructs and external influences from pilot research in mis-implementation and in evidence-based
decision-making [18, 21, 22, 31, 56, 57, 74] and draws on
previous literature from systems science on organizational
dynamics both within health systems and other fields
[91–96]. Findings from phases 1 and 2 will allow the
team to refine the core list of agent factors and also
estimate the relative importance of different agent
behaviors and attributes using a “bottom-up” approach
(i.e., real-world data collected from individuals and organizations). Several of the agent factors listed in Table 1 have
predicted mis-implementation in pilot research.
Individual Individual-level agents in the initial models
will represent the staff members who work within state
health departments. These individuals, who exist in a hierarchy within a state health department, include leaders,
managers, and coordinators (Fig. 3). The potential characteristics for modeling include their attitudes (e.g., openness
to innovation) [97], skills and knowledge (e.g., ability to use
economic evaluation) [31, 56], and barriers (e.g., lack of
knowledge of EBDM processes) [57, 98], specifically those
that may contribute to mis-implementation. Individual
agents will also have social connections with other agents
that affect how information flows through the organization
and how organization-level decisions about implementation
are made.
Organizational The second set of planned agents are
organizations representing state health departments.
These organizations have characteristics that influence
mis-implementation [22]. Several organizational agent
characteristics likely to affect mis-implementation are
management supports [18, 56], resources [52, 99], and
organizational barriers [31, 57].
Contextual (external) factors In addition, the team
plans to model external contextual factors. While these
are not directly present within health departments, context can have a significant influence on whether program
strategies are continued or discontinued. The initial set
of external factors has been drawn from pilot research
and previous conceptual frameworks and includes variables such as a diverse, multi-disciplinary set of partners
with EBDM skills [18, 32], funding climate, policy inputs, and political support [52]. The exploration of
external factors within the models will allow the team to
observe how agents adapt to different contexts—including through departmental and organizational communication channels—and how adaptation affects outcomes
related to mis-implementation [34].
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Developing the computational simulation

The development of the ABM will follow established
computational modeling best practices [100]. The modeling process will have four key steps:
Step 1: model design and internal consistency testing
Design of the models begins with identification of key
concepts and structures from the literature and pilot studies, as well as phases 1 and 2 and their operationalization
into appropriate model constructs. Table 1 is a start from
the pilot data and will be refined from what the team
learns in phases 1 and 2. The models are then implemented in computational architecture, with each piece
undergoing testing to ensure appropriate representation
of concepts and implementation. Revisions of initial
models’ implementation are undertaken as needed based
on partial model testing and consultation with experts.
Step 2: test for explanatory insights Once the initial
models are complete, the generative explanatory power of
the models to reproduce real-world observations about
mis-implementation can be tested under a variety of
different conditions. The testing procedure will have two
parts. In part one, the ABM will be used to examine misimplementation related to ending programs that should
continue. In part two, the team will examine misimplementation related to continuing programs that
should end. For each type of mis-implementation, the
team will focus on the ability of the models to reproduce
“stylized facts” about mis-implementation obtained from
pilot studies, activities in phases 1 and 2, and from the advisory group. These “stylized facts” are used to calibrate
the models and include variables such as how skilled individuals are in EBDM and how strongly the organizational
climate and culture supports EBDM. The engagement of
the advisory group will be essential in this step.
Step 3: sensitivity analyses Systematic exploration of
model behavior will be undertaken as key parameters and
assumptions are systematically varied. During this step, the
model’s contextual environmental factors will be held constant, allowing the team to explore the sensitivity and dependency of outcomes (patterns of mis-implementation) to
changes in assumptions about agent behavior and characteristics. Leveraging computational power to build up a robust statistical portrait of model dynamics and parameters,
where assumptions are systematically varied, will allow for
appropriate interpretation of model behavior, including the
relationships between individual, organizational, and external contextual factors.
Step 4: model analysis to generate insights by manipulating potential levers In this step, the team will
introduce changes in individual and organizational agent
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knowledge and behavior and in contextual variables to
explore effects on mis-implementation. This will help
point to modifiable individual and organizational agent
characteristics that, if addressed, can reduce misimplementation in a variety of external conditions (i.e., essential leverage points). The ABMs can provide not only
aggregate outcomes, but also information about how the
relative importance and effect of different factors may vary
across contexts and state health departments.
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of literature and terminology. To bridge these sectors, a
common lexicon will assist in accelerating progress by facilitating comparisons of methods and findings, supporting
methods’ development and communication across disciplinary areas, and identifying gaps in knowledge [102, 103].
When we began the pilot work for this project in 2014
[22], we cataloged a number of established, relevant
terms related to our scope, including:
 De-implementation: “abandoning ineffective medical

Discussion
Mis-implementation has not been studied nor have
adequate measures been developed to fully assess its impact in the field of population-based cancer control and
prevention. This study is timely and important because
(1) cancer is highly preventable, yet existing evidencebased interventions are not being adequately applied
despite their potential impact; (2) pilot research shows
that mis-implementation in cancer control is widespread;
and (3) ABM is a useful tool to more fully understand
mis-implementation complexities and dynamics. Results
from this study can help shape and inform how state
health departments guide and implement effective cancer
control programs as well as continue to test the utilization
of agent-based modeling to inform chronic disease and
cancer control research.
Furthering the debate about terminology

As the multi-disciplinary field of implementation science
has developed over the past 15 years, scholars from diverse
professions have attempted to document the many overlapping and sometimes inconsistently defined terms [101].
Many important contributions to implementation science
originate from non-health sectors (e.g., agriculture, marketing, communications, management), increasing the breadth

Fig. 4 Conceptualization of the definition of mis-implementation











practices and mitigating the risks of untested
practices [23]”;
De-adoption: “rejection of a medical practice or
health service found to be ineffective or harmful
following a previous period of adoption… [104]”;
Termination: “the deliberate conclusion or cessation
of specific government functions, programs, policies
or organizations [105]”;
Overuse: “clinical care in the absence of a clear
medical basis for use or when the benefit of therapy
does not outweigh risks [106]”;
Underuse: “the failure to deliver a health service that
is likely to improve the quality or quantity of life,
which is affordable [107]”;
Misuse: typically synonymous with “medical errors
[108]”

Because the goal of our project is to describe and
model two related phenomena (ending of effective interventions or continuation of ineffective interventions),
there was not an existing term that described the dual
processes that we are addressing. Figure 4 depicts the bidirectional meaning of mis-implementation. The green
cells show the desired implementation of effective programs and de-implementation of ineffective programs.
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The orange cells show the undesirable ending of effective programs and continuation of ineffective programs,
which we label as mis-implementation. We welcome input on terminology as we learn more about these processes. We hypothesize that some of the underlying
reasons and interaction of agents may differ for ending
effective interventions versus continuing ineffective interventions. This will allow us to continue to refine terminology over time.
While planning the current project, we also realized
that the use of the term mis-implementation may give
some practitioners unease in that our study might reflect
negatively on their day-to-day programs to decisionmakers (e.g., public health leaders, policy makers), rather
than identifying areas for improvement. These concerns
have been addressed with a practice advisory group from
the beginning of the project, and the team intends to
frame the study goals carefully, including use of a project
title and description that imparts positive, actionable
outcomes: “Public Health in Appropriate Continuation
of Tested Interventions” (Public Health in ACTION).
Utility of agent-based modeling

A strength of the study is the use of ABMs in combination
with quantitative and qualitative methods to provide
insights about how and why mis-implementation occurs
and how specific policies may affect mis-implementation.
These ABMs will explicate the dynamic interaction between individual decision-makers operating within organizations and influenced by external factors. An important
policy utility comes from using the models to capture how
variation in existing individual and organizational factors
may reduce mis-implementation. Experiments using the
models will allow comparison of baseline outcomes to
outcomes as individual and organizational factors are
changed to represent potential intervention scenarios.
Insights generated by the models can be used to design
novel strategies and policies that have the potential to effectively reduce mis-implementation. As these strategies
become evident, the team will frequently seek input from
the advisory group in order to maximize the real-world
utility of the findings.
Like all ABMs, the planned models will require the
team to make certain stylized assumptions about realworld structures and processes, especially when relevant
data are not available. Translating the data the team collects in the initial phases of the project into the models
in order to characterize individual and organizational behavior will require us to identify the most appropriate
factors for inclusion, and develop appropriate ways to
quantify these in a computational framework [43]. Many
elements included in the models—including those related to external support and opposition for programs,
barriers to decision-making, organizational climate, and
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individual capacity—although theoretically justified, are
inherently difficult to measure and quantify. Therefore,
while the models will elucidate important dynamics involved in mis-implementation and identify key leverage
points for improving decision-making, they are not
intended to provide precise, quantitative forecasts of
how organizational changes will affect implementation
decisions. Additionally, this is the first known attempt to
computationally model the process involved in the implementation and mis-implementation of programs
within health departments. As such, future modeling
may be warranted to further enhance our findings and
apply the models to other specific contexts.
Limitations

The study has a few limitations. While the team has plans
to ensure the highest response rates [72, 73], high turnover and workload demand of state health department
workers may impede data collection efforts [109, 110].
Based on previous research and state-of-the-art methods
[51, 52, 54, 72, 73], the team will take multiple steps to
ensure a high response rate and will also compare respondents with non-respondents. There are limitations on how
fully and accurately survey self-report responses can capture mis-implementation frequency and patterns across
complex multi-faceted statewide programs.
Summary

A richer understanding of mis-implementation will help
us better allocate already limited resources more efficiently, especially among health departments where a
significant portion of cancer control work is contracted
or performed in the USA [22]. This knowledge will also
allow researchers and practitioners to prevent the continuation of ineffective programs or discontinuation of
effective programs [22]. The team anticipates that the
study will result in replicable models that can significantly impact mis-implementation in cancer control and
can be applied to other health areas.

Endnotet
1
We use the term “programs” broadly to include a
wide range of interventions from structured behavioral
change strategies to broad policy approaches to cancer
screening promotion initiatives.
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